Have you or your loved ones been diagnosed with acute biphenotypic leukemia?

You may be eligible to participate in a acute biphenotypic leukemia clinical trial.

Have you or your loved ones been diagnosed with acute biphenotypic leukemia? You may be eligible to participate in a acute biphenotypic leukemia clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Acute Biphenotypic Leukemia Clinical Trial in Seattle WA
NCT00719888 | Phase 2 | Interventional

Have you or your loved ones been diagnosed with acute biphenotypic leukemia?

You may be eligible to participate in a acute biphenotypic leukemia clinical trial.

Have you or your loved ones been diagnosed with acute biphenotypic leukemia? You may be eligible to participate in a acute biphenotypic leukemia clinical trial.

Active not recruiting

Male & Female

6 Months -
45 Years

This study has recruited 135 Participants

This phase II trial studies how well giving an umbilical cord blood transplant together with cyclophosphamide, fludarabine, and total-body irradiation (TBI) works in treating patients with hematologic disease. Giving chemotherapy, such as cyclophosphamide and fludarabine, and TBI before a donor umbilical cord blood transplant helps stop the growth of cancer and abnormal cells and helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells. Giving cyclosporine and mycophenolate mofetil after transplant may stop this from happening.